Working forward to a more integrated neuroscience.
I also want to acknowledge @robincarhartharris.bsky.social , whose work has been inspiration for my personal visions and research direction, and also @ruffini.bsky.social for his methodological insights and great conversations at the Brain Modes conference!
I also want to acknowledge @robincarhartharris.bsky.social , whose work has been inspiration for my personal visions and research direction, and also @ruffini.bsky.social for his methodological insights and great conversations at the Brain Modes conference!
In the subacute group, ΔT (condition - baseline scans) correlated with the “affect” subscale of the Hallucinogen Rating Scale (HRS), p < 0.01 and was better explained in the ayahuasca group (adj. R² = 0.58) compared to the placebo (adj. R² = -0.05).
In the subacute group, ΔT (condition - baseline scans) correlated with the “affect” subscale of the Hallucinogen Rating Scale (HRS), p < 0.01 and was better explained in the ayahuasca group (adj. R² = 0.58) compared to the placebo (adj. R² = -0.05).
With less prominent network changes in subacute dataset.
With less prominent network changes in subacute dataset.
The main method infer Ising temperature using a GNN model, developed by me and published in Network Neuroscience (Cabral-Carvalho et al., 2025).
The main method infer Ising temperature using a GNN model, developed by me and published in Network Neuroscience (Cabral-Carvalho et al., 2025).
• Acute dataset: n=8 regular ayahuasca users, fMRI pre vs. 40 min post-dose
• Subacute dataset: n=19 aya vs. n=18 placebo, fMRI pre vs. 24 h post
• Analyses: graph metrics (segregation, clustering, path-length, modularity, etc.) + Ising temperature
• Acute dataset: n=8 regular ayahuasca users, fMRI pre vs. 40 min post-dose
• Subacute dataset: n=19 aya vs. n=18 placebo, fMRI pre vs. 24 h post
• Analyses: graph metrics (segregation, clustering, path-length, modularity, etc.) + Ising temperature